Delivery Order SPE2DB20D7066-SPE2DB25FC1PB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,282.48 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dobutamine 500 mg/250 ml in D5W solution. This firm fixed-price delivery order, valued at $2,139.28, is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's established capability to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,174.18 on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.50 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 15, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the point of performance for this pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W (dextrose 5% in water) solution. This order, valued at $3,004.49, was competitively awarded on August 15, 2025, with a completion date of August 18, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside award. Performance will be fulfilled from AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,679.76 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 ml in D5W solution. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The delivery order was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $4,658.91 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes a firm fixed price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.04 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W 250 mL on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the supply of a critical cardiovascular medication used in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This firm fixed-price delivery order, valued at $1,686.34, represents a non-competitive set-aside order and is scheduled for completion by August 14, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution. This delivery order, valued at $1,158.36 with a firm fixed price structure, represents a competitively awarded, non-set-aside procurement designed to support federal medical supply requirements. The contract is scheduled for ultimate completion on May 5, 2025, with performance taking place at AmerisourceBergen's...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC1PBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order was issued without a set-aside designation, indicating the award resulted from open competition. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with DLA for pharmaceutical products and medical supplies across multiple therapeutic domains, demonstrating the company's capability to meet federal healthcare requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/4/24 |